US 8642649
Orally dispersible tablet
granted A61KA61K31/343A61K9/0056
Quick answer
US patent 8642649 (Orally dispersible tablet) held by Takeda Pharmaceutical Company Limited expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/343, A61K9/0056, A61K9/006, A61K9/2013